Study finds that patients who took 400 milligrams of Celebrex® once daily significantly reduced their incidence of potentially pre-malignant colorectal polyps.
A bubble bath that improves memory. A kitchen cleaner that wards off nausea and energizes. A scented handkerchief that calms a patient entering the MRI. The benefits of aromatherapy are real. Below, learn the uses, healing properties and how-tos of using aromatherapy to heal and de-stress from The University of Texas M. D. Anderson Cancer Center in Houston.
September is Prostate Cancer and Gynecologic Cancer Awareness Month, which makes it the perfect time to focus on the prevention and early detection of prostate and gynecologic cancers.
A molecular "off" switch packaged in a tiny sphere penetrates deeply into ovarian cancer tumor cells, stifling a troublesome protein and drastically reducing the size of tumors, researchers at The University of Texas M. D. Anderson Cancer Center report in the Aug. 15 edition of Clinical Cancer Research.
Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays. And for the first time, the prospect of eradicating a specific cancer through vaccination is possible. The newly approved human papillomavirus (HPV) vaccine is designed to curb the 230,000 worldwide deaths due to cervical cancer, which is caused solely by HPV.
A single gene plays a pivotal role launching two DNA damage detection and repair pathways in the human genome, suggesting that it functions as a previously unidentified tumor suppressor gene, researchers at The University of Texas M. D. Anderson Cancer Center report in Cancer Cell.
Edward T.H. Yeh, M.D., professor and chair of the Department of Cardiology at The University of Texas M. D. Anderson Cancer Center has been elected to membership in the Academia Sinica, the most prestigious scholarly institution in the Republic of China.
Franco DeMonte, M.D., professor and deputy chair of the Department of Neurosurgery at The University of Texas M. D. Anderson Cancer Center, has been named president-elect of the North American Skull Base Society.
Launching a new era in radiation treatment, The University of Texas M. D. Anderson Cancer Center has started treating patients at its Proton Therapy Center.
Researchers at The University of Texas M. D. Anderson Cancer Center have significantly refined the scientific understanding of how a cell begins the process of self-destruction - an advance they say may help in the design of more targeted cancer therapies.
Obesity in a patient is an independent predictor of whether localized prostate cancer will progress following radiotherapy treatment, say researchers at M. D. Anderson Cancer Center.
A medication used to treat other types of cancer strangles drug-resistant, metastatic prostate cancer by cutting off its blood supply, researchers from The University of Texas M. D. Anderson Cancer Center report in the June 7 issue of the Journal of the National Cancer Institute.
The first clinical trial to evaluate a new type of drug that activates "death" receptors on cancer cells has found it to be both safe and suggestive of potential benefit, say researchers from The University of Texas M. D. Anderson Cancer Center.
In an ongoing effort to scientifically validate the age-old belief that mind-body interventions have a beneficial impact on the health of cancer patients, researchers at The University of Texas M. D. Anderson Cancer Center have shown that breast cancer patients who participate in a yoga program during treatment have improved quality of life, compared to patients who do not.
Researchers at The University of Texas M. D. Anderson Cancer Center have received a $2.4 million grant from the National Cancer Institute to study the effects of Tibetan yoga in women with breast cancer who are undergoing chemotherapy.
Brain tumor specialists at The University of Texas M. D. Anderson Cancer Center are poised on the brink of a new era.
An engineered virus tracks down and infects the most common and deadly form of brain cancer and then kills tumor cells by forcing them to devour themselves, researchers at The University of Texas M. D. Anderson Cancer Center report this week in the Journal of the National Cancer Institute.
A novel vaccine has significantly increased life expectancy in patients with glioblastoma multiforme (GBM), the most dangerous type of brain tumor, a researcher from The University of Texas M. D. Anderson Cancer Center is reporting at the annual meeting of the American Association of Neurological Surgeons (AANS).
Researchers at The University of Texas M. D. Anderson Cancer Center have created a new class of hybrid virus and demonstrated its ability to find, highlight, and deliver genes to tumors in mice.
The University of Texas M. D. Anderson Cancer Center received the Small Business Administration's Dwight D. Eisenhower Award for Excellence in Research and Development. This marks the first time a comprehensive cancer center has been honored with the Eisenhower Award.
When it comes to chemotherapy treatment for women whose breast cancer has spread to their lymph nodes, the estrogen status of their tumors matters, says a team of researchers in the April 12 issue of the Journal of the American Medical Association.
Physicians have little to help them predict development of lung cancer in their patients - even a history of heavy smoking doesn't really help, since only a small fraction of lifetime smokers develops the cancer.
Breast cancer patients with HER2-positive tumors who don't respond to Herceptin (trastuzumab) may benefit from cocktail therapy that includes Herceptin along with one or more PI3K inhibiting agents, say researchers at The University of Texas M. D. Anderson Cancer Center.
In their quest to determine whether immune system surveillance guards against brain tumor development, researchers have found that allergies and asthma that stimulate inflammation may be protective, but use of antihistamines to control the inflammation could eliminate that protection.
Studying thousands of people, researchers have documented a 25 percent increased risk of developing one of a number of cancers in first-degree relatives of lung cancer patients who have never smoked compared to families of people who neither smoke nor have lung cancer.
To increase awareness of skin cancer risks and prevention strategies, renowned experts on the front lines of skin cancer research, treatment and patient care answer important questions about skin cancer risk factors, sunscreen and skin protection and skin cancer screening and treatment.
When Houston restaurateur Tony Masraff was diagnosed with early-stage prostate cancer, his life was packed with dancing, running marathons, playing tennis, gardening, leading a successful business and spending time with his family.
A potent member of a new class of drugs increases survival in some patients with myelodysplastic syndrome (MDS), and may become the new standard of therapy for this group of pre-cancer disorders.
For his breakthrough research in cancer therapy, John Mendelsohn, M.D., president of The University of Texas M. D. Anderson Cancer Center, has been named co-recipient of a 2006 Dan David Prize, which was announced in Paris.
Researchers at The University of Texas M. D. Anderson Cancer Center report that they have created a way for viral and gold particles to "directly assemble" and potentially seek out and treat disease where it resides in the body.
The University of Texas M. D. Anderson Cancer Center has been awarded a National Cancer Institute Specialized Programs of Research Excellence (SPORE) grant for breast cancer research, the 10th such grant earned by the institution since 1996.
Physicians now have a tool to help monitor patients with a history of bladder cancer that is four times more effective than the conventional laboratory test in detecting the disease, according to a study.
As we enter the era of personalized medicine, it is time to take a fresh look at how we evaluate new medicines and treatments for cancer, according to Donald Berry, Ph.D., professor and chair of the Department of Biostatistics and Applied Mathematics at The University of Texas M. D. Anderson Cancer Center.
Can most types of cancers be prevented? It's a question that has emerged in the past 20 years, given advances in screening and early diagnosis, rapid developments in genetics and molecular biology, and progress in the treatment of early disease and in next-generation targeted therapies.
The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center (meeting abstract #37).
Early detection through screening mammography and improved adjuvant treatment have contributed almost equally to the substantial decrease in breast cancer death rates over the past 10 to 15 years, researchers conclude in an unprecedented effort to parse out the factors that have led to the decline.
Curcumin, the main ingredient of turmeric and the compound that gives curry its mustard-yellow color, inhibits metastasis to the lungs of mice with breast cancer, report researchers at The University of Texas M. D. Anderson Cancer Center.
An analysis of 20 years of data on the health of over 900 adults has found that long-term use of traditional nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, cuts the risk for oral cancer in smokers by half.
How heavy a man is at the time he is diagnosed with prostate cancer, as well as his history of weight gain, appear to play significant roles in how aggressive his cancer may become, say researchers at The University of Texas M. D. Anderson Cancer Center.
The molecular roots of inflammatory and autoimmune diseases such as asthma, arthritis, and multiple sclerosis have been discovered by a team of researchers. They say their findings may point to ways to effectively treat these diseases - if not stop them before they start.
Eating vegetables and other foods that have weak estrogen-like activity appears to reduce the risk of developing lung cancer in smokers "” as well as in non-smokers, say researchers at The University of Texas M. D. Anderson Cancer Center.
Researchers at The University of Texas M. D. Anderson Cancer Center report they have discovered a potential oncogene in ovarian cancer, which is the leading cause of gynecological cancer death in U.S. women.
Phase I cancer studies, trials that are conducted to determine the safety and maximum dose of a new agent, are under-reported in peer-reviewed journals - a trend that could ultimately delay scientific progress and negatively affect patient care, say researchers.
Researchers have found that an experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma, even though prior therapy had eliminated virtually all of the B cells thought necessary to mount such a defense.
Women whose breast cancer was detected by screening mammography had a significantly better prognosis than those whose cancer was found another way - even if the cancer had already spread to their lymph nodes, say researchers who looked at outcomes from randomized screening studies of more than 150,000 women.
Texas philanthropists Red and Charline McCombs have given The University of Texas M. D. Anderson Cancer Center $30 million, the largest gift ever made to support cancer research at the institution.
After a lengthy re-evaluation process and the addition of new monitoring guidelines, The University of Texas M. D. Anderson Cancer Center has reactivated a lung cancer chemoprevention trial studying celecoxib, an anti-inflammatory medication also known as Celebrex(r).
The University of Texas M. D. Anderson Cancer Center names Patricia M. Neal the recipient of the 2005 Ethel Fleming Arceneaux Outstanding Nurse-Oncologist Award, the institution's most prestigious honor in oncology nursing.
Researchers at The University of Texas M. D. Anderson Cancer Center may have uncovered the reason why some people who are genetically predisposed to hormone-dependent cancers develop the disease as an adult, while others who are similarly susceptible don't.
Researchers have located a gene dubbed dead end that when mutated or lost, causes testicular tumors in mice. They say their study will likely offer future insights into the genetic causes of the disease in humans because the cancer originates from the same cell type, the primordial germ cell, in both mice and men.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right